Catharus ustulatus isolate bCatUst1 chromosome 29, bCatUst1.pri.v2, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Turdidae; Catharus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM020364.1.\nAssembly name: bCatUst1.pri.v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2020/12/22. The original whole-genome shotgun project has the\naccession WNMQ00000000.2.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 06-AUG-2020\nAssembly Method :: FALCON v. DX 1.9.0; FALCON-Unzip v.\n 6.0.0.47841; purge_dups github v.\n purge_haplotig (bitbucket v1.0.3+\n 1.Nov.2018); Scaff10x v. 2; Bionano Solve\n v. 3.2.1_04122018; Salsa2 HiC v. 2.2;\n Arrow polishing and gap filling v.\n Smrtlink_6.0.0.47841; Longranger Align v.\n 2.2.2; freebayes v. 1.3.1; gEVAL manual\n curation v. 2020-08-06; VGP assembly\n pipeline v. 1.5\nAssembly Name :: bCatUst1.pri.v2\nDiploid :: Principal pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 60.58x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Catharus ustulatus Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
mitochondrial uncoupling protein 3-like, transcript variant X21
COORDINATES: polyA evidence [ECO:0006239]
mitochondrial uncoupling protein 3-like, transcript variant X20
mitochondrial uncoupling protein 3-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mitochondrial uncoupling protein 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mitochondrial uncoupling protein 3-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitochondrial uncoupling protein 3-like, transcript variant X2
mitochondrial uncoupling protein 3-like, transcript variant X1
mitochondrial uncoupling protein 3-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitochondrial uncoupling protein 3-like, transcript variant X4
mitochondrial uncoupling protein 3-like, transcript variant X17
mitochondrial uncoupling protein 3-like, transcript variant X9
mitochondrial uncoupling protein 3-like, transcript variant X8
mitochondrial uncoupling protein 3-like, transcript variant X10
mitochondrial uncoupling protein 3-like, transcript variant X18
mitochondrial uncoupling protein 3-like isoform X6
mitochondrial uncoupling protein 2-like isoform X10
mitochondrial uncoupling protein 3-like isoform X1
mitochondrial uncoupling protein 3-like isoform X3
mitochondrial uncoupling protein 3-like isoform X4
mitochondrial uncoupling protein 3-like isoform X11
mitochondrial uncoupling protein 3-like, transcript variant X13
mitochondrial uncoupling protein 3-like, transcript variant X16
mitochondrial uncoupling protein 3-like isoform X7
mitochondrial uncoupling protein 3-like, transcript variant X15
mitochondrial uncoupling protein 3-like isoform X9
mitochondrial uncoupling protein 3-like, transcript variant X5
uncharacterized protein LOC117008512 isoform X2
mitochondrial uncoupling protein 3-like, transcript variant X19
mitochondrial uncoupling protein 3-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitochondrial uncoupling protein 3-like, transcript variant X14
mitochondrial uncoupling protein 2-like isoform X12
mitochondrial uncoupling protein 3-like isoform X5
mitochondrial uncoupling protein 3-like isoform X8
protein sidekick-2-like, transcript variant X1
protein sidekick-2-like, transcript variant X2
protein sidekick-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium homeostasis endoplasmic reticulum protein, transcript variant X1
calcium homeostasis endoplasmic reticulum protein, transcript variant X2
calcium homeostasis endoplasmic reticulum protein isoform X2
calcium homeostasis endoplasmic reticulum protein isoform X1
chromosome 29 C19orf44 homolog, transcript variant X3
chromosome 29 C19orf44 homolog, transcript variant X1
uncharacterized protein C19orf44 homolog isoform X3
uncharacterized protein C19orf44 homolog isoform X1
chromosome 29 C19orf44 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein C19orf44 homolog isoform X2
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X5
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X4
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
epidermal growth factor receptor substrate 15-like 1 isoform X1
epidermal growth factor receptor substrate 15-like 1 isoform X2
epidermal growth factor receptor substrate 15-like 1 isoform X3
epidermal growth factor receptor substrate 15-like 1 isoform X5
epidermal growth factor receptor substrate 15-like 1 isoform X4
epidermal growth factor receptor substrate 15-like 1 isoform X6
adaptor related protein complex 1 subunit mu 1
family with sequence similarity 32 member A
calcium and integrin binding family member 3, transcript variant X1
calcium and integrin binding family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
calcium and integrin-binding family member 3 isoform X1
calcium and integrin-binding family member 3 isoform X2
ubiquitin domain-containing protein TINCR-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
protein tyrosine phosphatase receptor type S
receptor-type tyrosine-protein phosphatase S
lysine demethylase 4B, transcript variant X2
lysine demethylase 4B, transcript variant X1
lysine-specific demethylase 4B isoform X2
lysine-specific demethylase 4B isoform X1
ubiquitin like with PHD and ring finger domains 1, transcript variant X4
ubiquitin like with PHD and ring finger domains 1, transcript variant X1
ubiquitin like with PHD and ring finger domains 1, transcript variant X2
ubiquitin like with PHD and ring finger domains 1, transcript variant X3
E3 ubiquitin-protein ligase UHRF1 isoform X1
E3 ubiquitin-protein ligase UHRF1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
TIR domain-containing adapter molecule 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
TNF alpha induced protein 8 like 1, transcript variant X2
TNF alpha induced protein 8 like 1, transcript variant X1
TNF alpha induced protein 8 like 1, transcript variant X3
tumor necrosis factor alpha-induced protein 8-like protein 1 isoform X1
tumor necrosis factor alpha-induced protein 8-like protein 1 isoform X2
hepatoma-derived growth factor-related protein 2 isoform X5
hepatoma-derived growth factor-related protein 2 isoform X4
hepatoma-derived growth factor-related protein 2 isoform X3
hepatoma-derived growth factor-related protein 2 isoform X2
hepatoma-derived growth factor-related protein 2 isoform X1
UBX domain protein 6, transcript variant X1
UBX domain protein 6, transcript variant X2
UBX domain-containing protein 6 isoform X1
UBX domain-containing protein 6 isoform X2
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
MPN domain containing, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
MPN domain containing, transcript variant X2
MPN domain containing, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
MPN domain-containing protein isoform X3
MPN domain-containing protein isoform X2
MPN domain-containing protein isoform X1
signal transducing adaptor family member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
fibronectin type III and SPRY domain containing 1, transcript variant X1
fibronectin type III and SPRY domain containing 1, transcript variant X2
fibronectin type III and SPRY domain-containing protein 1 isoform X2
fibronectin type III and SPRY domain-containing protein 1 isoform X1
Src homology 2 domain containing transforming protein D
YJU2 splicing factor homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
YJU2 splicing factor homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein M, transcript variant X1
heterogeneous nuclear ribonucleoprotein M, transcript variant X2
heterogeneous nuclear ribonucleoprotein M isoform X1
heterogeneous nuclear ribonucleoprotein M isoform X2
heterogeneous nuclear ribonucleoprotein M, transcript variant X3
heterogeneous nuclear ribonucleoprotein M isoform X3
translocase of inner mitochondrial membrane 44, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 8 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
translocase of inner mitochondrial membrane 44, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
mitochondrial import inner membrane translocase subunit TIM44
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain 24, transcript variant X2
ankyrin repeat domain 24, transcript variant X3
ankyrin repeat domain 24, transcript variant X1
ankyrin repeat domain-containing protein 24 isoform X2
ankyrin repeat domain-containing protein 24 isoform X3
ankyrin repeat domain-containing protein 24 isoform X1
NAD-dependent protein deacetylase sirtuin-6
cAMP responsive element binding protein 3 like 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1
cAMP responsive element binding protein 3 like 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X2
mitogen-activated protein kinase kinase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 9 ESTs, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
dual specificity mitogen-activated protein kinase kinase 2
zinc finger and BTB domain containing 7A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
zinc finger and BTB domain containing 7A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 7A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
eukaryotic translation elongation factor 2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00440
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC117008273, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC117008273, transcript variant X2
ATCAY kinesin light chain interacting caytaxin, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ATCAY kinesin light chain interacting caytaxin, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ATCAY kinesin light chain interacting caytaxin, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dihydrouridine synthase 3 like, transcript variant X1
dihydrouridine synthase 3 like, transcript variant X3
tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like isoform X1
tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like isoform X3
dihydrouridine synthase 3 like, transcript variant X2
tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like isoform X2
MPV17 mitochondrial inner membrane protein like 2, transcript variant X2
MPV17 mitochondrial inner membrane protein like 2, transcript variant X1
phosphodiesterase 4C, transcript variant X1
phosphodiesterase 4C, transcript variant X2
phosphodiesterase 4C, transcript variant X3
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X2
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X1
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X3
JunD proto-oncogene, AP-1 transcription factor subunit
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm4
pyroglutamyl-peptidase I, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
pyroglutamyl-peptidase I, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
leucine-rich repeat-containing protein 25-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
elongation factor for RNA polymerase II, transcript variant X1
elongation factor for RNA polymerase II, transcript variant X2
RNA polymerase II elongation factor ELL isoform X1
RNA polymerase II elongation factor ELL isoform X2
peptidyl-prolyl cis-trans isomerase FKBP8
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant X2
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant X1
required for excision 1-B domain containing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
required for excision 1-B domain containing, transcript variant X1
required for excision 1-B domain-containing protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 59 like, transcript variant X1
transmembrane protein 59 like, transcript variant X2
transmembrane protein 59-like isoform X1
transmembrane protein 59-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CREB regulated transcription coactivator 1, transcript variant X1
CREB regulated transcription coactivator 1, transcript variant X5
CREB regulated transcription coactivator 1, transcript variant X6
CREB regulated transcription coactivator 1, transcript variant X8
CREB regulated transcription coactivator 1, transcript variant X2
CREB regulated transcription coactivator 1, transcript variant X3
CREB regulated transcription coactivator 1, transcript variant X4
CREB regulated transcription coactivator 1, transcript variant X7
CREB-regulated transcription coactivator 1 isoform X1
CREB-regulated transcription coactivator 1 isoform X5
CREB-regulated transcription coactivator 1 isoform X6
CREB-regulated transcription coactivator 1 isoform X8
CREB-regulated transcription coactivator 1 isoform X2
CREB-regulated transcription coactivator 1 isoform X3
CREB-regulated transcription coactivator 1 isoform X4
CREB-regulated transcription coactivator 1 isoform X7
uncharacterized LOC117008374, transcript variant X2
uncharacterized LOC117008374, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: cartilage oligomeric matrix protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: regulator of nonsense transcripts 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: embryonic growth/differentiation factor 1
uncharacterized LOC117008360, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC117008360, transcript variant X4
uncharacterized LOC117008360, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC117008360, transcript variant X2
uncharacterized LOC117008360, transcript variant X1
uncharacterized protein LOC117008360 isoform X4
uncharacterized protein LOC117008360 isoform X3
uncharacterized protein LOC117008360 isoform X2
uncharacterized protein LOC117008360 isoform X1
uncharacterized protein LOC117008360 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX49
homer scaffold protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
homer scaffold protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
homer scaffold protein 3, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: SURP and G-patch domain-containing protein 2
armadillo repeat containing 6, transcript variant X5
armadillo repeat containing 6, transcript variant X1
armadillo repeat containing 6, transcript variant X4
armadillo repeat containing 6, transcript variant X2
armadillo repeat containing 6, transcript variant X3
armadillo repeat-containing protein 6 isoform X1
armadillo repeat-containing protein 6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial coenzyme A transporter SLC25A42
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transmembrane protein 161A
myocyte enhancer factor 2B, transcript variant X1
myocyte enhancer factor 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
regulatory factor X associated ankyrin containing protein, transcript variant X2
regulatory factor X associated ankyrin containing protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
hyaluronan and proteoglycan link protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
LOW QUALITY PROTEIN: SURP and G-patch domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
NADH:ubiquinone oxidoreductase subunit A13
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13
YjeF N-terminal domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
YjeF N-terminal domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
yjeF N-terminal domain-containing protein 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 6 codons; deleted 20 bases in 18 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 6 codons; deleted 20 bases in 18 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: cartilage intermediate layer protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
GTP binding protein 3, mitochondrial, transcript variant X3
GTP binding protein 3, mitochondrial, transcript variant X4
GTP binding protein 3, mitochondrial, transcript variant X2
GTP binding protein 3, mitochondrial, transcript variant X1
tRNA modification GTPase GTPBP3, mitochondrial isoform X3
tRNA modification GTPase GTPBP3, mitochondrial isoform X4
tRNA modification GTPase GTPBP3, mitochondrial isoform X2
tRNA modification GTPase GTPBP3, mitochondrial isoform X1
39S ribosomal protein L34, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
USH1 protein network component harmonin binding protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77% coverage of the annotated genomic feature by RNAseq alignments
Usher syndrome type-1C protein-binding protein 1
nuclear receptor subfamily 2 group F member 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 28 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
bifunctional endo-1,4-beta-xylanase XylA-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
small conductance calcium-activated potassium channel protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 124-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
coiled-coil domain-containing protein 124-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
coiled-coil domain-containing protein 124-like, transcript variant X3
coiled-coil domain-containing protein 124-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
coiled-coil domain-containing protein 124-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
coiled-coil domain-containing protein 124-like isoform X2
coiled-coil domain-containing protein 124-like isoform X1
coiled-coil domain-containing protein 124-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
coiled-coil domain-containing protein 124-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain containing 124, transcript variant X2
coiled-coil domain containing 124, transcript variant X3
coiled-coil domain containing 124, transcript variant X1
coiled-coil domain containing 124, transcript variant X4
coiled-coil domain-containing protein 124 isoform X1
coiled-coil domain-containing protein 124 isoform X2
small conductance calcium-activated potassium channel protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
small conductance calcium-activated potassium channel protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
small conductance calcium-activated potassium channel protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
small conductance calcium-activated potassium channel protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
small conductance calcium-activated potassium channel protein 1-like isoform X1
small conductance calcium-activated potassium channel protein 1-like isoform X2
small conductance calcium-activated potassium channel protein 1-like isoform X4
small conductance calcium-activated potassium channel protein 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
cocaine- and amphetamine-regulated transcript protein-like
growth arrest and DNA damage inducible beta
growth arrest and DNA damage-inducible protein GADD45 beta
G protein subunit gamma 7, transcript variant X3
G protein subunit gamma 7, transcript variant X1
G protein subunit gamma 7, transcript variant X2
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
solute carrier family 39 member 3, transcript variant X1
solute carrier family 39 member 3, transcript variant X2
small glutamine rich tetratricopeptide repeat co-chaperone alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
small glutamine rich tetratricopeptide repeat co-chaperone alpha, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
small glutamine rich tetratricopeptide repeat co-chaperone alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
small glutamine-rich tetratricopeptide repeat-containing protein alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
proprotein convertase subtilisin/kexin type 4
receptor accessory protein 6, transcript variant X1
receptor accessory protein 6, transcript variant X2
receptor expression-enhancing protein 6 isoform X2
receptor expression-enhancing protein 6 isoform X1
chromosome 29 C19orf25 homolog, transcript variant X3
chromosome 29 C19orf25 homolog, transcript variant X2
chromosome 29 C19orf25 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
APC regulator of WNT signaling pathway 2, transcript variant X2
APC regulator of WNT signaling pathway 2, transcript variant X3
APC regulator of WNT signaling pathway 2, transcript variant X1
APC regulator of WNT signaling pathway 2, transcript variant X4
DAZ associated protein 1, transcript variant X2
DAZ associated protein 1, transcript variant X1
DAZ associated protein 1, transcript variant X3
guanidinoacetate N-methyltransferase, transcript variant X1
guanidinoacetate N-methyltransferase, transcript variant X2
NADH:ubiquinone oxidoreductase core subunit S7
NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
PWWP domain containing 3A, DNA repair factor, transcript variant X2
PWWP domain containing 3A, DNA repair factor, transcript variant X1
PWWP domain-containing DNA repair factor 3A
calcium/calmodulin-dependent protein kinase type IV-like, transcript variant X4
calcium/calmodulin-dependent protein kinase type IV-like, transcript variant X5
calcium/calmodulin-dependent protein kinase type IV-like, transcript variant X6
calcium/calmodulin-dependent protein kinase type IV-like, transcript variant X2
calcium/calmodulin-dependent protein kinase type IV-like, transcript variant X3
calcium/calmodulin-dependent protein kinase type IV-like, transcript variant X1
calcium/calmodulin-dependent protein kinase type IV-like, transcript variant X7
caM kinase-like vesicle-associated protein isoform X3
caM kinase-like vesicle-associated protein isoform X4
calcium/calmodulin-dependent protein kinase type IV-like isoform X6
calcium/calmodulin-dependent protein kinase type 1-like isoform X5
caM kinase-like vesicle-associated protein isoform X2
caM kinase-like vesicle-associated protein isoform X1
family with sequence similarity 174 member C, transcript variant X2
family with sequence similarity 174 member C, transcript variant X1
cold inducible RNA binding protein, transcript variant X3
cold inducible RNA binding protein, transcript variant X1
cold inducible RNA binding protein, transcript variant X2
cold-inducible RNA-binding protein isoform X2
cold-inducible RNA-binding protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ATP synthase subunit delta, mitochondrial
CACN subunit beta associated regulatory protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
LOW QUALITY PROTEIN: voltage-dependent calcium channel beta subunit-associated regulatory protein
serine/threonine kinase 11, transcript variant X2
serine/threonine kinase 11, transcript variant X1
strawberry notch homolog 2, transcript variant X1
strawberry notch homolog 2, transcript variant X2
protein strawberry notch homolog 2 isoform X1
strawberry notch homolog 2, transcript variant X3
protein strawberry notch homolog 2 isoform X2
phospholipid hydroperoxide glutathione peroxidase
DNA-directed RNA polymerases I, II, and III subunit RPABC1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 ESTs, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ATP binding cassette subfamily A member 7
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
transmembrane protein 259, transcript variant X1
transmembrane protein 259, transcript variant X2
glutamate ionotropic receptor NMDA type subunit 3B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
AT-rich interactive domain-containing protein 3A
mediator complex subunit 16, transcript variant X1
mediator complex subunit 16, transcript variant X2
mediator of RNA polymerase II transcription subunit 16
phospholipid phosphatase related 3, transcript variant X2
phospholipid phosphatase related 3, transcript variant X1
phospholipid phosphatase related 3, transcript variant X3
phospholipid phosphatase-related protein type 3 isoform X1
phospholipid phosphatase-related protein type 3 isoform X2
polypyrimidine tract binding protein 1, transcript variant X1
polypyrimidine tract binding protein 1, transcript variant X2
polypyrimidine tract-binding protein 1 isoform X1
polypyrimidine tract-binding protein 1 isoform X2
uncharacterized protein KIAA1958 homolog
mitotic spindle positioning, transcript variant X2
mitotic spindle positioning, transcript variant X1
mitotic interactor and substrate of PLK1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RNA polymerase mitochondrial, transcript variant X1
RNA polymerase mitochondrial, transcript variant X2
DNA-directed RNA polymerase, mitochondrial isoform X1
DNA-directed RNA polymerase, mitochondrial isoform X2
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2
basigin (Ok blood group), transcript variant X1
basigin (Ok blood group), transcript variant X2
cell division cycle 34, ubiqiutin conjugating enzyme
tubulin polyglutamylase complex subunit 1
mucosal vascular addressin cell adhesion molecule 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: mucosal addressin cell adhesion molecule 1
hippocampus abundant transcript 1 protein-like
SHC adaptor protein 2, transcript variant X1
SHC adaptor protein 2, transcript variant X2
SHC adaptor protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
C2 calcium dependent domain containing 4C
C2 calcium-dependent domain-containing protein 4C
MIER family member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
MIER family member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
MIER family member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
mesoderm induction early response protein 2 isoform X1
mesoderm induction early response protein 2 isoform X3
mesoderm induction early response protein 2 isoform X2
MIER family member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
mesoderm induction early response protein 2 isoform X4
transducin-like enhancer protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transducin-like enhancer protein 1, transcript variant X1
transducin-like enhancer protein 1, transcript variant X2
transducin-like enhancer protein 1, transcript variant X4
transducin-like enhancer protein 1, transcript variant X3
transducin-like enhancer protein 1, transcript variant X5
transducin-like enhancer protein 1 isoform X1
transducin-like enhancer protein 1 isoform X2
transducin-like enhancer protein 1 isoform X4
transducin-like enhancer protein 1 isoform X3
transducin-like enhancer protein 1 isoform X5
transducin-like enhancer protein 2, transcript variant X2
transducin-like enhancer protein 2, transcript variant X4
transducin-like enhancer protein 2, transcript variant X3
transducin-like enhancer protein 2, transcript variant X1
transducin-like enhancer protein 2 isoform X2
transducin-like enhancer protein 2 isoform X4
transducin-like enhancer protein 2 isoform X3
transducin-like enhancer protein 2 isoform X1
transducin-like enhancer protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
TLE family member 5, transcriptional modulator, transcript variant X2
TLE family member 5, transcriptional modulator, transcript variant X1
guanine nucleotide-binding protein subunit alpha-11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 14 ESTs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CUGBP Elav-like family member 5, transcript variant X1
CUGBP Elav-like family member 5, transcript variant X2
CUGBP Elav-like family member 5 isoform X1
CUGBP Elav-like family member 5, transcript variant X3
CUGBP Elav-like family member 5, transcript variant X4
CUGBP Elav-like family member 5 isoform X2
CUGBP Elav-like family member 5 isoform X3
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X3
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X2
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X1
hydroxysteroid 11-beta-dehydrogenase 1-like protein
mitochondrial contact site and cristae organizing system subunit 13
scaffold attachment factor B1-like, transcript variant X2
scaffold attachment factor B1-like isoform X2
scaffold attachment factor B1-like, transcript variant X1
scaffold attachment factor B1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
scaffold attachment factor B1-like isoform X1
mediator of RNA polymerase II transcription subunit 26
transmembrane protein 38A, transcript variant X1
trimeric intracellular cation channel type A isoform X1
transmembrane protein 38A, transcript variant X2
trimeric intracellular cation channel type A isoform X2
SIN3 transcription regulator family member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X2
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X4
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X2
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X3
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X1
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X2
rho guanine nucleotide exchange factor 18 isoform X1
rho guanine nucleotide exchange factor 18 isoform X2
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X3
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X4
rho guanine nucleotide exchange factor 18 isoform X3
ectoderm-neural cortex protein 1-like, transcript variant X2
ectoderm-neural cortex protein 1-like, transcript variant X1
arrestin domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
arrestin domain-containing protein 2 isoform X2
arrestin domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
arrestin domain-containing protein 2 isoform X1
interleukin 12 receptor subunit beta 1, transcript variant X4
interleukin 12 receptor subunit beta 1, transcript variant X5
interleukin 12 receptor subunit beta 1, transcript variant X2
interleukin 12 receptor subunit beta 1, transcript variant X3
interleukin 12 receptor subunit beta 1, transcript variant X1
interleukin-12 receptor subunit beta-1 isoform X4
interleukin-12 receptor subunit beta-1 isoform X5
interleukin-12 receptor subunit beta-1 isoform X2
interleukin-12 receptor subunit beta-1 isoform X3
interleukin-12 receptor subunit beta-1 isoform X1
microtubule associated serine/threonine kinase 3, transcript variant X5
microtubule-associated serine/threonine-protein kinase 3 isoform X5
microtubule associated serine/threonine kinase 3, transcript variant X1
microtubule associated serine/threonine kinase 3, transcript variant X7
microtubule associated serine/threonine kinase 3, transcript variant X2
microtubule-associated serine/threonine-protein kinase 3 isoform X1
microtubule-associated serine/threonine-protein kinase 3 isoform X2
microtubule-associated serine/threonine-protein kinase 3 isoform X7
microtubule associated serine/threonine kinase 3, transcript variant X3
microtubule associated serine/threonine kinase 3, transcript variant X4
microtubule-associated serine/threonine-protein kinase 3 isoform X3
microtubule-associated serine/threonine-protein kinase 3 isoform X4
microtubule associated serine/threonine kinase 3, transcript variant X6
microtubule-associated serine/threonine-protein kinase 3 isoform X6
phosphoinositide-3-kinase regulatory subunit 2, transcript variant X1
phosphoinositide-3-kinase regulatory subunit 2, transcript variant X2
phosphatidylinositol 3-kinase regulatory subunit beta
gamma-interferon-inducible lysosomal thiol reductase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
DNA-binding protein RFX2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
DNA-binding protein RFX2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
DNA-binding protein RFX2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
DNA-binding protein RFX2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DNA-binding protein RFX2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DNA-binding protein RFX2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
DNA-binding protein RFX2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
DNA-binding protein RFX2-like isoform X2
DNA-binding protein RFX2-like isoform X6
DNA-binding protein RFX2-like isoform X5
DNA-binding protein RFX2-like isoform X4
DNA-binding protein RFX2-like isoform X3
DNA-binding protein RFX2-like isoform X1
acyl-CoA synthetase bubblegum family member 2, transcript variant X3
acyl-CoA synthetase bubblegum family member 2, transcript variant X1
acyl-CoA synthetase bubblegum family member 2, transcript variant X2
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X1
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X2
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X3
MLLT1 super elongation complex subunit, transcript variant X1
MLLT1 super elongation complex subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
acidic leucine-rich nuclear phosphoprotein 32 family member B, transcript variant X1
acidic leucine-rich nuclear phosphoprotein 32 family member B, transcript variant X2
acidic leucine-rich nuclear phosphoprotein 32 family member B isoform X1
acidic leucine-rich nuclear phosphoprotein 32 family member B isoform X2
LOW QUALITY PROTEIN: zinc finger protein 414
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 7 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ADAM metallopeptidase with thrombospondin type 1 motif 10, transcript variant X1
ADAM metallopeptidase with thrombospondin type 1 motif 10, transcript variant X2
A disintegrin and metalloproteinase with thrombospondin motifs 10
tyrosine-protein kinase ZAP-70, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 11 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
tyrosine-protein kinase ZAP-70, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 8 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
tyrosine-protein kinase ZAP-70 isoform X1
tyrosine-protein kinase ZAP-70 isoform X2
C2 calcium-dependent domain-containing protein 4C-like
leucine rich repeat and Ig domain containing 3, transcript variant X2
leucine rich repeat and Ig domain containing 3, transcript variant X4
leucine rich repeat and Ig domain containing 3, transcript variant X5
leucine rich repeat and Ig domain containing 3, transcript variant X1
leucine rich repeat and Ig domain containing 3, transcript variant X3
leucine rich repeat and Ig domain containing 3, transcript variant X6
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: ornithine decarboxylase antizyme 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 10 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
splicing factor 3a subunit 2, transcript variant X2
splicing factor 3a subunit 2, transcript variant X1
pleckstrin homology domain containing J1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
pleckstrin homology domain-containing family J member 1
DOT1 like histone lysine methyltransferase, transcript variant X4
DOT1 like histone lysine methyltransferase, transcript variant X1
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X4
DOT1 like histone lysine methyltransferase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
DOT1 like histone lysine methyltransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X3
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X2
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X1
adaptor related protein complex 3 subunit delta 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: AP-3 complex subunit delta-1
MOB kinase activator 3A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
MOB kinase activator 3A-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
MOB kinase activator 3A-like, transcript variant X1
MOB kinase activator 3A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MOB kinase activator 3A-like, transcript variant X4
MOB kinase activator 3A-like, transcript variant X5
LOW QUALITY PROTEIN: AP-3 complex subunit delta-1-like
MOB kinase activator 3A, transcript variant X1
MOB kinase activator 3A, transcript variant X2
collagen alpha-1(III) chain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
collagen alpha-1(III) chain-like, transcript variant X2
MAPK interacting serine/threonine kinase 2
MAP kinase-interacting serine/threonine-protein kinase 2
casein kinase 1 gamma 2, transcript variant X2
casein kinase 1 gamma 2, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: secretory carrier-associated membrane protein 4
nuclear receptor ROR-beta-like, transcript variant X2
nuclear receptor ROR-beta-like isoform X2
nuclear receptor ROR-beta-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
nuclear receptor ROR-beta-like isoform X1
abhydrolase domain containing 17A, depalmitoylase
alpha/beta hydrolase domain-containing protein 17A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
transcription factor 3, transcript variant X1
transcription factor 3, transcript variant X2
transcription factor 3, transcript variant X4
transcription factor 3, transcript variant X5
transcription factor 3, transcript variant X3
transcription factor 3, transcript variant X6
transcription factor 3, transcript variant X7
transcription factor E2-alpha isoform X1
transcription factor E2-alpha isoform X2
transcription factor E2-alpha isoform X4
transcription factor E2-alpha isoform X5
transcription factor E2-alpha isoform X3
transcription factor E2-alpha isoform X6
transcription factor E2-alpha isoform X7
methyl-CpG binding domain protein 3, transcript variant X2
methyl-CpG-binding domain protein 3 isoform X2
methyl-CpG binding domain protein 3, transcript variant X4
methyl-CpG binding domain protein 3, transcript variant X3
methyl-CpG-binding domain protein 3 isoform X3
methyl-CpG-binding domain protein 3 isoform X4
methyl-CpG binding domain protein 3, transcript variant X1
methyl-CpG-binding domain protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
unc-13 homolog A, transcript variant X15
unc-13 homolog A, transcript variant X22
unc-13 homolog A, transcript variant X23
unc-13 homolog A, transcript variant X21
unc-13 homolog A, transcript variant X20
unc-13 homolog A, transcript variant X19
unc-13 homolog A, transcript variant X17
unc-13 homolog A, transcript variant X14
unc-13 homolog A, transcript variant X11
unc-13 homolog A, transcript variant X16
unc-13 homolog A, transcript variant X12
unc-13 homolog A, transcript variant X10
unc-13 homolog A, transcript variant X18
unc-13 homolog A, transcript variant X13
nuclear factor I C, transcript variant X2
nuclear factor I C, transcript variant X1
nuclear factor I C, transcript variant X3
nuclear factor I C, transcript variant X4
deoxyhypusine hydroxylase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
deoxyhypusine hydroxylase, transcript variant X1
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like
fizzy and cell division cycle 20 related 1, transcript variant X3
fizzy and cell division cycle 20 related 1, transcript variant X1
fizzy and cell division cycle 20 related 1, transcript variant X2
GRAM domain-containing protein 2A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
GRAM domain-containing protein 2A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
GRAM domain-containing protein 2A-like, transcript variant X3
GRAM domain-containing protein 2A-like, transcript variant X5
GRAM domain-containing protein 2A-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
GRAM domain-containing protein 2A-like, transcript variant X6
GRAM domain-containing protein 2A-like isoform X5
GRAM domain-containing protein 2A-like isoform X4
GRAM domain-containing protein 2A-like isoform X3
uncharacterized protein LOC117008405 isoform X1
uncharacterized protein LOC117008405 isoform X2
uncharacterized protein LOC117008405 isoform X6
GRAM domain-containing protein 2A-like, transcript variant X7
GRAM domain-containing protein 2A-like isoform X7
major facilitator superfamily domain containing 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
major facilitator superfamily domain-containing protein 12 isoform X1
major facilitator superfamily domain containing 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
major facilitator superfamily domain-containing protein 12 isoform X2
high mobility group 20B, transcript variant X2
high mobility group 20B, transcript variant X3
high mobility group 20B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
high mobility group 20B, transcript variant X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related isoform X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related isoform X2
GIPC PDZ domain containing family member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
thromboxane A2 receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
thromboxane A2 receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X9
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X6
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X4
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X3
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X5
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X2
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X8
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X1
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X9
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X6
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X4
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X3
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X5
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X2
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X8
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X1
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X7
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X7
tight junction protein 3, transcript variant X1
tight junction protein 3, transcript variant X2
amyloid beta precursor protein binding family A member 3, transcript variant X2
amyloid beta precursor protein binding family A member 3, transcript variant X1
amyloid-beta A4 precursor protein-binding family A member 3 isoform X2
amyloid-beta A4 precursor protein-binding family A member 3 isoform X1
39S ribosomal protein L54, mitochondrial
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like
LOW QUALITY PROTEIN: mucosa-associated lymphoid tissue lymphoma translocation protein 1-like
retina and anterior neural fold homeobox 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 15 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
retina and anterior neural fold homeobox protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
megakaryocyte-associated tyrosine kinase, transcript variant X2
megakaryocyte-associated tyrosine kinase, transcript variant X1
megakaryocyte-associated tyrosine kinase, transcript variant X3
megakaryocyte-associated tyrosine-protein kinase isoform X2
megakaryocyte-associated tyrosine-protein kinase isoform X1
megakaryocyte-associated tyrosine-protein kinase isoform X3
ELAV like RNA binding protein 1, transcript variant X1
ELAV like RNA binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
excitatory amino acid transporter 5-like
DNA polymerase epsilon 4, accessory subunit
bone morphogenetic protein 4-like, transcript variant X1
bone morphogenetic protein 4-like, transcript variant X2
potassium voltage-gated channel subfamily V member 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
NADH:ubiquinone oxidoreductase subunit A7
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7
KN motif and ankyrin repeat domains 3, transcript variant X1
KN motif and ankyrin repeat domains 3, transcript variant X2
KN motif and ankyrin repeat domain-containing protein 3
uncharacterized LOC117008479, transcript variant X1
uncharacterized LOC117008479, transcript variant X2
membrane associated ring-CH-type finger 2, transcript variant X2
membrane associated ring-CH-type finger 2, transcript variant X3
membrane associated ring-CH-type finger 2, transcript variant X1
E3 ubiquitin-protein ligase MARCHF2 isoform X1
E3 ubiquitin-protein ligase MARCHF2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
ceramide synthase 4-like, transcript variant X7
ceramide synthase 4-like, transcript variant X3
ceramide synthase 4-like, transcript variant X4
ceramide synthase 4-like, transcript variant X2
ceramide synthase 4-like, transcript variant X8
ceramide synthase 4-like, transcript variant X6
ceramide synthase 4-like, transcript variant X5
ceramide synthase 4-like, transcript variant X1
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm7
signal peptide peptidase like 2B, transcript variant X1
signal peptide peptidase like 2B, transcript variant X2
signal peptide peptidase like 2B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
signal peptide peptidase-like 2B isoform X1
signal peptide peptidase-like 2B isoform X2
signal peptide peptidase-like 2B isoform X3
transmembrane serine protease 9, transcript variant X2
transmembrane serine protease 9, transcript variant X1
transmembrane serine protease 9, transcript variant X3
transmembrane protease serine 9 isoform X1
transmembrane protease serine 9 isoform X2
translocase of inner mitochondrial membrane 13
mitochondrial import inner membrane translocase subunit Tim13
excitatory amino acid transporter 4-like, transcript variant X5
excitatory amino acid transporter 4-like, transcript variant X6
excitatory amino acid transporter 4-like isoform X2
excitatory amino acid transporter 4-like isoform X3
excitatory amino acid transporter 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
excitatory amino acid transporter 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
excitatory amino acid transporter 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
excitatory amino acid transporter 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
excitatory amino acid transporter 1-like isoform X1
RAN binding protein 3, transcript variant X1
RAN binding protein 3, transcript variant X2
NADH:ubiquinone oxidoreductase subunit A11
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11
platelet glycoprotein Ib alpha chain-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns